Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Andrew Pearson

Newcastle AuthorsTitleYearFull text
Professor Andrew Pearson
Professor Roderick Skinner
A global approach to long-term follow-up of targeted and immune-based therapy in childhood and adolescence2021
Professor Andrew Pearson
Dr Simon Bomken
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children2019
Professor Andrew Pearson
Dr Pamela Kearns
Professor Josef Vormoor
Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective2017
Professor Andrew Pearson
Professor Josef Vormoor
From class waivers to precision medicine in paediatric oncology2017
Nermine Basta
Dr Gail Halliday
Richard Feltbower
Dr Nicholas Bown
Professor Andrew Pearson
et al.		Factors associated with recurrence and survival length following relapse in patients with neuroblastoma2016
Professor Andrew Pearson
Dr Quentin Campbell Hewson
Professor Alan Boddy
Melanie Griffin
A Phase I Trial of AT9283 (a Selective Inhibitor of Aurora Kinases) in Children and Adolescents with Solid Tumors: A Cancer Research UK Study2015
Professor Deborah Tweddle
Professor Andrew Pearson
MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance2014
Professor Gareth Veal
Julie Errington
Sophie Rowbotham
Nicola Illingworth
Dr Ghada Malik
et al.		Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma2013
Nermine Basta
Dr Gail Halliday
Richard Feltbower
Dr Nicholas Bown
Professor Andrew Pearson
et al.		Factors associated with recurrence and length of survival following relapse in patients with neuroblastoma: a pilot study2012
Melanie Griffin
Professor Alan Boddy
Professor Andrew Pearson
Adaptation and Validation of the Plasma Inhibitory Activity (PIA) Assay to Detect Inhibition of Aurora, ABL and FLT3 kinases by AT9283 In Children and Adolescents with Leukaemia2010
Professor Roderick Skinner
Annie Parry
Lisa Price
Mike Cole
Professor Andrew Pearson
Glomerular Toxicity Persists 10 Years After Ifosfamide Treatment in Childhood and Is Not Predictable by Age or Dose2010
Dr Jane Carr-Wilkinson
Kieran O'Toole
Angela Baker
Julian Board
Mike Cole
et al.		High frequency of p53/MDM2/p14ARF pathway abnormalities in relapsed neuroblastoma2010
Professor Gareth Veal
Julie Errington
Professor Andrew Pearson
Professor Alan Boddy
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients2010
Professor Roderick Skinner
Annie Parry
Lisa Price
Mike Cole
Professor Andrew Pearson
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors2009
Dr Maria Lastowska
Dr Mauro Santibanez Koref
Ilka Wappler
Dr Heiko Peters
Emeritus Professor Andy Hall
et al.		Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data2007
1234567891011121314151617181920...>>